Synthesis of Ibuprofen Monoglyceride Using Novozym®435: Biocatalyst Activation and Stabilization in Multiphasic Systems

This work was focused on the enzymatic esterification of glycerol and ibuprofen at high concentrations in two triphasic systems composed of toluene+ibuprofene (apolar) and glycerol or glycerol–water (polar) liquid phases, and a solid phase with the industrial immobilized lipase B from Candida antarc...

Full description

Bibliographic Details
Published in:Catalysts
Main Authors: Marianela Ravelo, M. Esther Gallardo, Miguel Ladero, Felix Garcia-Ochoa
Format: Text
Language:English
Published: Multidisciplinary Digital Publishing Institute 2022
Subjects:
Online Access:https://doi.org/10.3390/catal12121531
_version_ 1821737469865885696
author Marianela Ravelo
M. Esther Gallardo
Miguel Ladero
Felix Garcia-Ochoa
author_facet Marianela Ravelo
M. Esther Gallardo
Miguel Ladero
Felix Garcia-Ochoa
author_sort Marianela Ravelo
collection MDPI Open Access Publishing
container_issue 12
container_start_page 1531
container_title Catalysts
container_volume 12
description This work was focused on the enzymatic esterification of glycerol and ibuprofen at high concentrations in two triphasic systems composed of toluene+ibuprofene (apolar) and glycerol or glycerol–water (polar) liquid phases, and a solid phase with the industrial immobilized lipase B from Candida antarctica named Novozym®435 (N435) acting as the biocatalyst. Based on a preliminary study, the concentration of the enzyme was set at 30 g·L−1 and the stirring speed at 720 r.p.m to reduce external mass transfer limitations. To obtain more information on the reaction system, it was conducted at a wide range of temperatures (50 to 80 °C) and initial concentrations of ibuprofen (20–100 g·L−1, that is, 97 to 483 mM). Under these experimental conditions, the external mass transfer, according to the Mears criterion (Me = 1.47–3.33·10−4 << 0.15), was fast, presenting no limitation to the system productivity, regardless of the presence of water and from 50 to 80 °C. Considering that the enzyme is immobilized in a porous ion-exchange resin, limitations due to internal mass transfer can exist, depending on the values of the effectiveness factor (η). It varied from 0.14 to 0.23 at 50 to 80 °C and 0.32–1 mm particle diameter range in the absence of water, and in the same ranges, from 0.40 to 0.66 in the presence of 7.4% w/w water in the glycerol phase. Thus, it is evident that some limitation occurs due to mass transfer inside the pores, while the presence of water in the polar phase increases the productivity 3–4 fold. During the kinetic study, several kinetic models were proposed for both triphasic reacting systems, with and without first-order biocatalyst deactivation, and their fit to all relevant experimental data led to the observation that the best kinetic model was a reversible hyperbolic model with first-order deactivation in the anhydrous reaction system and a similar model, but without deactivation, for the system with added water at zero time. This fact is in sharp contrast to the use of N435 in a water-glycerol ...
format Text
genre Antarc*
Antarctica
genre_facet Antarc*
Antarctica
id ftmdpi:oai:mdpi.com:/2073-4344/12/12/1531/
institution Open Polar
language English
op_collection_id ftmdpi
op_doi https://doi.org/10.3390/catal12121531
op_relation Biocatalysis
https://dx.doi.org/10.3390/catal12121531
op_rights https://creativecommons.org/licenses/by/4.0/
op_source Catalysts; Volume 12; Issue 12; Pages: 1531
publishDate 2022
publisher Multidisciplinary Digital Publishing Institute
record_format openpolar
spelling ftmdpi:oai:mdpi.com:/2073-4344/12/12/1531/ 2025-01-16T19:18:33+00:00 Synthesis of Ibuprofen Monoglyceride Using Novozym®435: Biocatalyst Activation and Stabilization in Multiphasic Systems Marianela Ravelo M. Esther Gallardo Miguel Ladero Felix Garcia-Ochoa 2022-11-28 application/pdf https://doi.org/10.3390/catal12121531 EN eng Multidisciplinary Digital Publishing Institute Biocatalysis https://dx.doi.org/10.3390/catal12121531 https://creativecommons.org/licenses/by/4.0/ Catalysts; Volume 12; Issue 12; Pages: 1531 ibuprofen monoglyceride toluene biphasic system Novozym ® 435 ester prodrug Text 2022 ftmdpi https://doi.org/10.3390/catal12121531 2023-08-01T07:32:46Z This work was focused on the enzymatic esterification of glycerol and ibuprofen at high concentrations in two triphasic systems composed of toluene+ibuprofene (apolar) and glycerol or glycerol–water (polar) liquid phases, and a solid phase with the industrial immobilized lipase B from Candida antarctica named Novozym®435 (N435) acting as the biocatalyst. Based on a preliminary study, the concentration of the enzyme was set at 30 g·L−1 and the stirring speed at 720 r.p.m to reduce external mass transfer limitations. To obtain more information on the reaction system, it was conducted at a wide range of temperatures (50 to 80 °C) and initial concentrations of ibuprofen (20–100 g·L−1, that is, 97 to 483 mM). Under these experimental conditions, the external mass transfer, according to the Mears criterion (Me = 1.47–3.33·10−4 << 0.15), was fast, presenting no limitation to the system productivity, regardless of the presence of water and from 50 to 80 °C. Considering that the enzyme is immobilized in a porous ion-exchange resin, limitations due to internal mass transfer can exist, depending on the values of the effectiveness factor (η). It varied from 0.14 to 0.23 at 50 to 80 °C and 0.32–1 mm particle diameter range in the absence of water, and in the same ranges, from 0.40 to 0.66 in the presence of 7.4% w/w water in the glycerol phase. Thus, it is evident that some limitation occurs due to mass transfer inside the pores, while the presence of water in the polar phase increases the productivity 3–4 fold. During the kinetic study, several kinetic models were proposed for both triphasic reacting systems, with and without first-order biocatalyst deactivation, and their fit to all relevant experimental data led to the observation that the best kinetic model was a reversible hyperbolic model with first-order deactivation in the anhydrous reaction system and a similar model, but without deactivation, for the system with added water at zero time. This fact is in sharp contrast to the use of N435 in a water-glycerol ... Text Antarc* Antarctica MDPI Open Access Publishing Catalysts 12 12 1531
spellingShingle ibuprofen
monoglyceride
toluene
biphasic system
Novozym ® 435
ester prodrug
Marianela Ravelo
M. Esther Gallardo
Miguel Ladero
Felix Garcia-Ochoa
Synthesis of Ibuprofen Monoglyceride Using Novozym®435: Biocatalyst Activation and Stabilization in Multiphasic Systems
title Synthesis of Ibuprofen Monoglyceride Using Novozym®435: Biocatalyst Activation and Stabilization in Multiphasic Systems
title_full Synthesis of Ibuprofen Monoglyceride Using Novozym®435: Biocatalyst Activation and Stabilization in Multiphasic Systems
title_fullStr Synthesis of Ibuprofen Monoglyceride Using Novozym®435: Biocatalyst Activation and Stabilization in Multiphasic Systems
title_full_unstemmed Synthesis of Ibuprofen Monoglyceride Using Novozym®435: Biocatalyst Activation and Stabilization in Multiphasic Systems
title_short Synthesis of Ibuprofen Monoglyceride Using Novozym®435: Biocatalyst Activation and Stabilization in Multiphasic Systems
title_sort synthesis of ibuprofen monoglyceride using novozym®435: biocatalyst activation and stabilization in multiphasic systems
topic ibuprofen
monoglyceride
toluene
biphasic system
Novozym ® 435
ester prodrug
topic_facet ibuprofen
monoglyceride
toluene
biphasic system
Novozym ® 435
ester prodrug
url https://doi.org/10.3390/catal12121531